SCHEMBL4723322

SCHEMBL4723322

CC(C)OC(=O)ON1CCC(Oc2cc(NCCOc3cc(F)ccc3F)ncn2)CC1

nearest known ligand 0.45

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 5/20 0.45
GPR6 P46095 9/20 0.37
ACACB O00763 2/20 0.37
HTR7 P34969 1/20 0.35
CHRM4 P08173 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL385942 0.89 GPR119 (0.57) GPR119
SCHEMBL4722977 0.85 GPR119 (0.55) GPR119GPR6ACACBCHRM4
SCHEMBL4719083 0.83 GPR119 (0.56) GPR119GPR6ACACB
SCHEMBL4718845 0.82 GPR119 (0.63) GPR119ACACB
SCHEMBL4720606 0.79 GPR119 (0.52) GPR119ACACB
SCHEMBL4719555 0.79 GPR119 (0.52) GPR119GPR6ACACB
SCHEMBL4718867 0.78 GPR119 (0.54) GPR119ACACB
SCHEMBL4721027 0.78 GPR119 (0.55) GPR119ACACB
SCHEMBL4721995 0.78 GPR119 (0.52) GPR119GPR6ACACB
SCHEMBL4721558 0.77 GPR119 (0.53) GPR119ACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1756084-B1 SUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO ARENA PHARM INC (US) 2008-11-26 EP claimed